Correction to: Military Medical Research (2022) 9:69 https://doi.org/10.1186/s40779-022-00433-9
Following publication of the original article [1], it was found there are some errors in the article.
The affiliations of the authors are incorrect, the correct author list with correct affiliations is shown below.
The Funding information should be updated to the below one:
This work was supported by the National Natural Science Foundation of China (52103181, 81873196), and the Fundamental Research Funds for the Central Universities (22120220075).
The original paper is updated.
Reference
Lu Y, Gao Y, Yang H, Hu Y, Li X. Nanomedicine-boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma. Mil Med Res. 2022;9(1):69. https://doi.org/10.1186/s40779-022-00433-9.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Lu, Y., Gao, Y., Yang, H. et al. Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma. Military Med Res 10, 5 (2023). https://doi.org/10.1186/s40779-023-00440-4
Published:
DOI: https://doi.org/10.1186/s40779-023-00440-4